Learn About Refsum Disease

What is the definition of Refsum Disease?

Refsum disease is an inherited condition that causes vision loss, absence of the sense of smell (anosmia), and a variety of other signs and symptoms.

What are the causes of Refsum Disease?

More than 90 percent of all cases of Refsum disease result from mutations in the PHYH gene. The remaining cases are caused by mutations in a gene called PEX7.

How prevalent is Refsum Disease?

The prevalence of Refsum disease is unknown, although the condition is thought to be uncommon.

Is Refsum Disease an inherited disorder?

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Who are the top Refsum Disease Local Doctors?
Elite in Refsum Disease
Medical Genetics | Pediatrics
Elite in Refsum Disease
Medical Genetics | Pediatrics
601 N Caroline St, 
Baltimore, MD 
Languages Spoken:
English

Nancy Braverman is a Medical Genetics specialist and a Pediatrics provider in Baltimore, Maryland. Dr. Braverman is rated as an Elite provider by MediFind in the treatment of Refsum Disease. Her top areas of expertise are Zellweger Syndrome, Chondrodysplasia Punctata Syndrome, X-Linked Chondrodysplasia Punctata 2, and Acromesomelic Dysplasia.

Elite in Refsum Disease
Elite in Refsum Disease
Amsterdam, NH, NL 

Ronald Wanders practices in Amsterdam, Netherlands. Mr. Wanders is rated as an Elite expert by MediFind in the treatment of Refsum Disease. His top areas of expertise are Zellweger Syndrome, Refsum Disease, Barth Syndrome, and Infantile Refsum Disease.

 
 
 
 
Learn about our expert tiers
Learn More
Peter F. Maurice
Experienced in Refsum Disease
Otolaryngology | Plastic Surgery | Pediatric Otolaryngology
Experienced in Refsum Disease
Otolaryngology | Plastic Surgery | Pediatric Otolaryngology

Proliance Surgeons

Three Tree Medical Building, 16259 Sylvester Rd SW, Suite 504, 
Burien, WA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Peter F. Maurice, MD, is a highly specialized otolaryngologist, and fellowship-trained in plastic surgery. He is double board-certified by the American Board of Facial Plastic and Reconstructive Surgery and the American Board of Otolaryngology.Dr. Maurice received his medical degree from Georgetown University, in Washington, DC, where he was elected to membership in the Alpha Omega Alpha Honor Medical Society. He completed his residency in otolaryngology–head and neck surgery at Georgetown University Hospital.Dr. Maurice then was selected for a fellowship in facial plastic and reconstructive surgery. This full-year training program gave him a unique opportunity to study with one of the AAFPRS's master surgeons in Albuquerque, New Mexico.At South Seattle Otolaryngology, patients benefit from a team of on-site audiologists and allergy specialists, in addition to a team of otolaryngologists with over 50 years of combined experience. Dr. Maurice is rated as an Experienced provider by MediFind in the treatment of Refsum Disease. His top areas of expertise are Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Low Nasal Bridge, Nasal Septal Hematoma, and Sinusitis.

What are the latest Refsum Disease Clinical Trials?
Longitudinal Natural History Study of Patients With Peroxisome Biogenesis Disorders (PBD)

Summary: The Peroxisome Biogenesis Disorders (PBD) are a group of inherited disorders due to defects in peroxisome assembly causing complex developmental and metabolic sequelae. In spite of advancements in peroxisome biology, the pathophysiology remains unknown, the spectrum of phenotypes poorly characterized and the natural history not yet systematically reported. Our aims are to further define this popul...

Match to trials
Find the right clinical trials for you in under a minute
Get started
The Myelin Disorders Biorepository Project and Global Leukodystrophy Initiative Clinical Trials Network

Summary: The Myelin Disorders Biorepository Project (MDBP) seeks to collect and analyze clinical data and biological samples from leukodystrophy patients worldwide to support ongoing and future research projects. The MDBP is one of the world's largest leukodystrophy biorepositories, having enrolled nearly 2,000 affected individuals since it was launched over a decade ago. Researchers working in the biorepo...

Who are the sources who wrote this article ?

Published Date: November 01, 2016
Published By: National Institutes of Health